|
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study |
|
|
|
Titel: |
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study |
Auteur: |
Xu, Jianming Shen, Lin Bai, Chunmei Wang, Wei Li, Jie Yu, Xianjun Li, Zhiping Li, Enxiao Yuan, Xianglin Chi, Yihebali Yin, Yongmei Lou, Wenhui Xu, Nong Bai, Yuxian Zhang, Tao Xiu, Dianrong Wang, Xiuwen Yuan, Ying Chen, Jia Qin, Shukui Jia, Ru Lu, Ming Cheng, Yuejuan Zhou, Zhiwei Li, Jing He, James Su, Weiguo |
Verschenen in: |
Lancet oncology |
Paginering: |
Jaargang 21 () nr. 11 pagina's 1489-1499 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|